• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Indivior - Articles and news items


Positive top-line results from Phase 3 trial of RBP-7000 in schizophrenia announced

Industry news / 6 May 2015 / Victoria White

Indivior has announced top-line results from its Phase 3 clinical trial of RBP-7000, an investigational drug for the treatment of schizophrenia…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +